Teachers Retirement System of The State of Kentucky Has $34.08 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Teachers Retirement System of The State of Kentucky trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 106,073 shares of the company’s stock after selling 471 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in HCA Healthcare were worth $34,079,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of HCA. FinTrust Capital Advisors LLC increased its position in HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after purchasing an additional 35 shares during the period. Lake Street Advisors Group LLC increased its holdings in HCA Healthcare by 1.3% in the second quarter. Lake Street Advisors Group LLC now owns 2,732 shares of the company’s stock worth $878,000 after purchasing an additional 35 shares in the last quarter. Financial Counselors Inc. lifted its position in shares of HCA Healthcare by 1.4% during the 1st quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after acquiring an additional 36 shares during the period. Premier Path Wealth Partners LLC raised its holdings in shares of HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after purchasing an additional 36 shares during the period. Finally, Westside Investment Management Inc. grew its stake in shares of HCA Healthcare by 14.7% in the 2nd quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after buying an additional 37 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 0.8 %

HCA Healthcare stock opened at $406.43 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $409.42. The firm has a 50 day simple moving average of $380.53 and a 200 day simple moving average of $343.58. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a market capitalization of $106.45 billion, a price-to-earnings ratio of 20.26, a P/E/G ratio of 1.52 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. During the same quarter last year, the company earned $4.29 EPS. The firm’s revenue was up 10.3% compared to the same quarter last year. On average, analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on HCA. Wells Fargo & Company upped their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Deutsche Bank Aktiengesellschaft lifted their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Royal Bank of Canada raised their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Finally, Morgan Stanley initiated coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective on the stock. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.